GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Equity-to-Asset

Zahravi Pharmacutical Co (XTEH:DZAH1) Equity-to-Asset : 0.00 (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Zahravi Pharmacutical Co's Total Stockholders Equity for the quarter that ended in . 20 was IRR0.00 Mil. Zahravi Pharmacutical Co's Total Assets for the quarter that ended in . 20 was IRR0.00 Mil.

The historical rank and industry rank for Zahravi Pharmacutical Co's Equity-to-Asset or its related term are showing as below:

XTEH:DZAH1's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.59
* Ranked among companies with meaningful Equity-to-Asset only.

Zahravi Pharmacutical Co Equity-to-Asset Historical Data

The historical data trend for Zahravi Pharmacutical Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Equity-to-Asset Chart

Zahravi Pharmacutical Co Annual Data
Trend
Equity-to-Asset

Zahravi Pharmacutical Co Semi-Annual Data
Equity-to-Asset

Competitive Comparison of Zahravi Pharmacutical Co's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Zahravi Pharmacutical Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zahravi Pharmacutical Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zahravi Pharmacutical Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Zahravi Pharmacutical Co's Equity-to-Asset falls into.



Zahravi Pharmacutical Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Zahravi Pharmacutical Co's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as

Equity to Asset (A: . 20 )=Total Stockholders Equity/Total Assets
=/
=

Zahravi Pharmacutical Co's Equity to Asset Ratio for the quarter that ended in . 20 is calculated as

Equity to Asset (Q: . 20 )=Total Stockholders Equity/Total Assets
=/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zahravi Pharmacutical Co  (XTEH:DZAH1) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Zahravi Pharmacutical Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Zahravi Pharmacutical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN
Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co Headlines

No Headlines